Shortly, Dr. Kai Lamottke has given an interview to Pharma Board room and disclosed the development of the company over the past 20 years in Germany and China: The success of business idea and promising anti-seizure drug as well as perfect collaboration strategy.
Moving forward, what are Bicoll’s main priorities?
To get the right people around the table, either inside the company or outside the company as collaboration partners to expand our knowledge about the next generation products which we are all interested in working on.
Read more online or as download Interview with pharmaboardroom.com.